Brazil Hyperglycemics Research
6 comprehensive market analysis studies and research reports on the Brazil Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 79 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.27%
Study Period: 2020 - 2031
Middle East And Africa Insulin Market
CAGR: 3.73%
Study Period: 2020 - 2031
Middle East And Africa Meglitinide Market
CAGR: 4%
Study Period: 2019 - 2030
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
North America Meglitinide Market
CAGR: 1.5%
Study Period: 2019 - 2030
Healthcare
Categories
6 Healthcare Reports
Categories
Showing 6 of 6 results in Hyperglycemics
Insulin Market
CAGR: 3.62%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Brazil
Major Players:Novo Nordisk, Eli Lilly and Company, Pfizer, Sanofi, Biocon Biologics Ltd.
Starting at:$4,750
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Market
CAGR: 8.05%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Brazil
Major Players:Janssen, Boehringer Ingelheim, Eli Lilly and Company, Astellas Pharma, AstraZeneca
Starting at:$4,750
Insulin Glargine Market
CAGR: 6.05%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Brazil
Major Players:Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar
Starting at:$4,750
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Brazil
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Starting at:$4,750
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: Brazil
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Starting at:$4,750
Biguanides Market
CAGR: 2.22%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: Brazil
Major Players:Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
